Benmoxin
Chemical compound
From Wikipedia, the free encyclopedia
Benmoxin (trade names Neuralex, Nerusil), also known as mebamoxine, is an irreversible and nonselective monoamine oxidase inhibitor (MAOI) of the hydrazine class.[1][2] It was synthesized in 1967 and was subsequently used as an antidepressant in Europe, but is now no longer marketed.[1][2]
ATC code
- None
Legal status
- In general: ℞ (Prescription only)
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.028.745 |
| Chemical and physical data | |
| Formula | C15H16N2O |
| Molar mass | 240.306 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |